Nomura Holdings’s VanEck Biotech ETF BBH Stock Holding History

Nomura Holdings’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-499	Closed	-$34K	–	2325
2013 Q2	$34K	Buy	+499	New	+$34.7K	﹤0.01%	2095

Other funds holding BBH

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FMI

Factory Mutual Insurance Waltham, Massachusetts $8.89B AUM 25.87% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AHS

Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return

Nomura Holdings's BBH Position: Q3 2013 in Review

Nomura Holdings sold out of VanEck Biotech ETF (BBH) in Q3 2013, closing a stake of 499 shares — an estimated $34K sold.

Nomura Holdings first reported a position in BBH in Q2 2013 and held it in 1 quarter. The position peaked at $34K in Q2 2013. 39 funds tracked by Wall St. Rank hold BBH as of Q3 2013.

Nomura Holdings reported no remaining VanEck Biotech ETF position as of Q3 2013 after selling out during the quarter.
Nomura Holdings sold 499 VanEck Biotech ETF shares in Q3 2013, an estimated $34K.
Nomura Holdings first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 1 quarter.
Nomura Holdings's VanEck Biotech ETF position peaked at $34K in Q2 2013.
39 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2013.

Based on Nomura Holdings's 13F filing for Q3 2013, filed 14 Nov 2013.